To determine whether MC-dependent adverse events have similar underlying immune mechanisms, we compared the IL-18 plasma levels of patients with the cutAE subtype urticaria to patients with T-cell-driven cutaneous AEs and colitis. The gene discussed is IL18; the disease is colitis.